Cargando…

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

Triple-negative breast cancer (TNBC) lacks effective treatment options due to the absence of traditional therapeutic targets. The epidermal growth factor receptor (EGFR) has emerged as a promising target for TNBC therapy because it is overexpressed in about 50% of TNBC patients. Here we describe a P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yu-Cheng, Burnouf, Pierre-Alain, Chuang, Kuo-Hsiang, Chen, Bing-Mae, Cheng, Tian-Lu, Roffler, Steve R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472176/ https://www.ncbi.nlm.nih.gov/pubmed/28593948 http://dx.doi.org/10.1038/ncomms15507

Ejemplares similares

Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines
por: Chen, Wei-An, et al.
Publicado: (2023)

Mimicking the germinal center reaction in hybridoma cells to isolate temperature-selective anti-PEG antibodies
por: Su, Yu-Cheng, et al.
Publicado: (2014)

Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles
por: Hsieh, Yuan-Chin, et al.
Publicado: (2016)

Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)
por: Bavli, Yaelle, et al.
Publicado: (2023)

Reversible glycosidic switch for secure delivery of molecular nanocargos
por: Burnouf, Pierre-Alain, et al.
Publicado: (2018)

PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
por: Bavli, Yaelle, et al.
Publicado: (2020)

Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
por: Hsieh, Yuan-Chin, et al.
Publicado: (2018)

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
por: Cheng, Yi-An, et al.
Publicado: (2020)

Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation
por: Burnouf, Thierry, et al.
Publicado: (2019)

Development of Morphologically Discrete PEG–PDLLA Nanotubes for Precision Nanomedicine
por: Wauters, Annelies C., et al.
Publicado: (2018)

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity
por: Ho, Kai-Wen, et al.
Publicado: (2021)

PEGylation of Goldbody: PEG-aided conformational engineering of peptides on gold nanoparticles
por: Gao, Tiange, et al.
Publicado: (2022)

PEGylated Paclitaxel Nanomedicine Meets 3D Confinement: Cytotoxicity and Cell Behaviors
por: Lin, Wenhai, et al.
Publicado: (2023)

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
por: Lin, Wen-Wei, et al.
Publicado: (2021)

Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis
por: Teles, Ramon Handerson Gomes, et al.
Publicado: (2018)

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
por: Ichihara, Masako, et al.
Publicado: (2010)

Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
por: Fang, Yan, et al.
Publicado: (2017)

Nanomedicines in the treatment of chronic hepatitis C – focus on pegylated interferon alpha-2a
por: Thomas, Thea, et al.
Publicado: (2007)

Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
por: Su, Chia-Yu, et al.
Publicado: (2018)

High-Throughput Sorting of the Highest Producing Cell via a Transiently Protein-Anchored System
por: Chuang, Kuo-Hsiang, et al.
Publicado: (2014)

Safety of PEGylated recombinant human full‐length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates
por: Stidl, R., et al.
Publicado: (2015)

Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity
por: Lin, Hsien-Ya, et al.
Publicado: (2021)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

On-demand PEGylation and dePEGylation of PLA-based nanocarriers via amphiphilic mPEG-TK-Ce6 for nanoenabled cancer chemotherapy
por: Zhu, Yueqiang, et al.
Publicado: (2019)

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
por: Chen, Yao, et al.
Publicado: (2018)

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV – focus on pegylated interferon-alpha
por: Zoller, Heinz, et al.
Publicado: (2006)

Probing the subcutaneous absorption of a PEGylated FUD peptide nanomedicine via in vivo fluorescence imaging
por: Zbyszynski, Pawel, et al.
Publicado: (2019)

Novel Therapeutic Approach in PEGylated Chitosan Nanoparticles of Apigenin for the Treatment of Cancer via Oral Nanomedicine
por: Mujtaba, Md Ali, et al.
Publicado: (2022)

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023)

Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer
por: Shindikar, Amol, et al.
Publicado: (2016)

Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines
por: Dirisala, Anjaneyulu, et al.
Publicado: (2020)

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
por: Yau, Thomas, et al.
Publicado: (2012)

Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase
por: Zhang, Chun, et al.
Publicado: (2012)

PEGylation of Octreotide Using an α,β-unsaturated-β′-mono-sulfone Functionalized PEG Reagent
por: Erfani-Jabarian, Laleh, et al.
Publicado: (2012)

Normal Insulin Secretion from Immune-Protected Islets of Langerhans by PEGylation and Encapsulation in the Alginate-Chitosan-PEG
por: Najafikhah, Nahid, et al.
Publicado: (2018)

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
por: Sandoughdaran, Saleh, et al.
Publicado: (2015)

High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation
por: Al-Aghbar, Mohammad Ameen, et al.
Publicado: (2018)

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
por: Burrows, Natalie, et al.
Publicado: (2016)

PEGylation of Superparamagnetic Iron Oxide Nanoparticles with Self-Organizing Polyacrylate-PEG Brushes for Contrast Enhancement in MRI Diagnosis
por: Illés, Erzsébet, et al.
Publicado: (2018)

Data on the removal of peroxides from functionalized polyethylene glycol (PEG) and effects on the stability and sensitivity of resulting PEGylated conjugates
por: Babity, Samuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jcnho3a3m974mh0hff0v13u3i9